Private Equity
Pharos Capital Group LLC said Oct. 30 it acquired a majority stake in Charter Health Care Group. Financial terms weren’t announced. Charter Health is a post-acute care provider offering hospice, home health, and transitional care services.
3 min read · 30 October 2018
New York City-based Work-Bench, an enterprise-focused venture fund and community, raised more than $46.2 million for its second fund, according to a regulatory filing. Work-Bench was co-founded by General Partners Jonathan Lehr and Jessica Lin in 2013. It is based in a 32,000-square-foot office in Union Square where it hosts events and operates an enterprise tech hub.
1 min read · 29 October 2018
3 min read · 29 October 2018
ARCH Venture Partners is seeking to raise $600 million for its tenth fund, according to an SEC filing. The Chicago-based venture firm makes seed/early-stage investments in tech firms.
1 min read · 29 October 2018
Caisse de dépôt et placement du Québec (CDPQ) has launched Cheffes de file, an initiative intended to help grow women-led companies in Québec. Cheffes de file will operate as a collaboration platform, bringing women entrepreneurs together to share best practices. Additionally, participants will be provided with value-adding resources and information, as well as access to local and global networks of coaches and experts. Cheffes de file will include about 50 women who are decision-makers and shareholders of Québec companies with sales ranging from $5 million to $20 million.
3 min read · 29 October 2018
San Leandro, California-based Geltor, which designs animal-and GMO-free designer proteins, including collagen, announced last week it raised $18.2 million in a Series A round of funding. Cultivian Sandbox Ventures led the financing, which included GELITA, ADM Ventures, Cavallo Ventures and Box Group. The company, founded in 2015, has now raised $23 million to date.
1 min read · 29 October 2018
2 min read · 26 October 2018
Maven Ventures is seeking to raise $50 million for its third fund, according to an SEC filing. The Palo Alto, California-based venture firm invests in consumer software and mobile startups.
1 min read · 26 October 2018
Galecto Biotech AB, a developer of galectin modulators for the treatment of severe diseases, has raised 79 million euros in Series C financing. The investors included Novo Seeds, M Ventures, Sunstone Capital, Ysios Capital, OrbiMed, HBM Healthcare Investments, Bristol Myers-Squibb, Maverick Ventures and Seventure Partners. As a result of the transaction, Novo Seeds is now the largest shareholder in Galecto.
1 min read · 26 October 2018
2 min read · 25 October 2018
